In preliminary experiments, the compound 2-amino-5-(2-sulfamoylphenyl)-1,3,4-thiadiazole (G413) was shown to possess high activity against DNA viruses (herpes simplex viruses 1 and 2 and adenovirus 17) and RNA viruses (poliovirus 1, echovirus 2, and coxsackievirus B4). Experiments on the replicative cycle of poliovirus 1 and production of infectious RNA viruses demonstrate that this compound probably prevents assembly of virus particles by acting on structural proteins. In the present experiments, results concerning the activity of derivatives of G413 after side-chain modification are reported. Modification of the primary amine H to CH3 or CH2-CH=CH2 produced a loss of activity against DNA viruses, but inhibitory action on RNA viruses was preserved. Modification to CH2CH3 resulted in the loss of antiviral activity.
The relationship between structure and antiviral activity, apart from its intrinsic importance in the chemotherapy of DNA and RNA virus infections, may make it possible to establish a theoretical approach which can be applied to every class of antiviral compounds yet to be discovered.
Thompson et al. showed that a thiosemicarbazone molecule must have both a side chain and a cyclic component to possess antiviral activity (7) . Bauer and Sadler studied the relationship between isatin-beta-thiosemicarbazone structure and its antiviral activity in much greater detail (1) .
Recently, La Colla et al. have studied the effects of different pyrimidine derivatives on the growth of DNA and RNA viruses and shown that 2-amino-4,6-dichloropyrimidine is the most active derivative (6) .
The thiadiazole nucleus is important in compounds with antimicrobial and antitumor activity (3, 8) . We have studied the antiviral activity of 2-amino-5-(2-sulfamoylphenyl)-1 ,3,4-thiadiazole (G413) (2) . This compound is effective in inhibiting the replication of some RNA viruses (poliovirus 1, echovirus 2, and coxsackievirus B4) and DNA viruses (herpes simplex viruses 1 and 2 [HSV-1, HSV-2] and adenovirus 17 [Adl7]) at concentrations which did not exhibit any toxic effects on cells in vitro.
The maximum noncytotoxic doses of drugs were determined in HEp-2 cells (107 cells per sample) incubated in Eagle minimal essential medium at 370C for 48 h. Cell damage was checked both by direct observation at low mnagnification and by measuring the amount of neutral red incorporated spectrophotometrically at 530 nm. The maximum noncytotoxic doses were (in micrograms per milliliter) 900 (G413), 800 (G444 and G445), and 1,300 (G480). The G413 was synthesized in our laboratories (Italian application for patent 49013A/80, 19 June 1980); 1,2-benzisothiazole-3(2H)-thione-1,1-dioxide and thiosemicarbazide were heated under reflux in butanol. The product was obtained as white or yellowish crystals soluble in alcohol, ethyl acetate, diluted alkaline solutions, and dimethyl sulfoxide. The structural formulas of G413 and derivatives are reported in Fig. 1 .
HSV-1 and Adl7 were used as DNA viruses, and poliovirus 1, coxsackievirus B4, and echovirus 2 were used as RNA viruses. The viruses were grown, tested, and titrated on human aneuploid HEp-2 cells. Samples of 106 cells were infected with 10 infectious units per cell, washed three times in Hanks buffered saline solution, and incubated at 37°C. Drugs were added at time zero postinfection; in all experiments 0 h postinfection refers to the time of addition of fresh medium contarining different concentrations of the compounds after virus attachment. After 24 h, the whole cultures were frozen and thawed (-70 and +20°C) three times and freed of cell debris at 3,000 rpm. Infectious units produced by viruses were titrated by a modification of the methods of Dulbecco (4).
All our results are reported in Table 1 . G413 reduced HSV-1 replication by 2 logs at a concentration of 100 ,ug/ml and reduced Adl7 replication by over 6 logs at a concentration of 50 ,ug/ml. G413 inhibited poliovirus 1 replication by over 6 logs at a concentration of 50 ,ug/ml, but a significant reduction had been observed with 20 ,ug/ml. Similar results were obtained on coxsackievirus B4 replication since 50 pg of G413 per ml reduced the virus titer by over 5 logs. Finally, G413 completely inhibited the echovirus 2 virion production at a concentration of 50 g.g/ml.
The CH3 derivative of G413 (G444) shows a different activity. None of the concentrations tested was able to inhibit HSV-1 and Adl7 replication in HEp-2 cells. On the other hand, the activity of G444 on Picornaviridae was similar to that of G413.
Parallel effects were found with the CH27CH=CH2 derivative (G445): no antiviral effects on DNA viruses were demonstrated; on the contrary a concentration of 50 ,ug/ml reduced poliovirus replication by 5 logs and coxsackievirus B4 replication by over 4 logs ( Table 1 ).
The CH2-CH3 derivative (G480) did not inhibit RNA or DNA virus replication.
The results obtained in vitro strongly suggest that the compound G413 possesses an inhibitory spectrum on virion production against DNA and RNA viruses; at the same time, this compound does not prevent virus-induced cytopathic effects. In experiments carried out on poliovirus, it did not reduce infectious RNA production (2). The RNA was extracted by the method of Gierer and Schramm (5) and tested on HEp-2 cells.
The introduction of CH3 or CH2-CH=CH2 into the G413 molecule caused a loss of anti-DNA virus activity, but the anti-RNA virus activity was preserved.
The negative results obtained with the G480 compound suggest that the side chain is one of the most critical points of our compounds. 
